NasdaqGS:SNDXBiotechs
Is It Too Late To Consider Syndax Pharmaceuticals (SNDX) After A 116% One-Year Surge?
To move beyond the headline moves in Syndax Pharmaceuticals and really understand whether the current share price offers value, you need to look at how the stock compares on a few different valuation measures.
The shares last closed at US$24.25, with returns of 3.2% over 30 days, 13.8% year to date and 115.7% over the past year. This naturally raises questions about whether expectations or risk perceptions have shifted.
Recent coverage has focused on Syndax Pharmaceuticals as part of the...